Blue Foot Membranes
PrivateLast Round
Growth Equity
Jul 2, 2024
Total Funding Raised
$19.09M
Momentum Score
75 /100
Company Overview
Blue Foot Membranes is a Belgian environmental technology company that provides innovative membrane solutions for wastewater treatment. Spun off from the VITO research institute in 2017, the company developed and patented the Integrated Permeate Channel (IPC®) membrane, a unique, unbreakable, and backwashable flat sheet membrane for Membrane Bioreactor (MBR) applications. This technology is designed to be more durable, energy-efficient, and compact, offering a lower total cost of ownership compared to conventional membranes. The company targets both industrial and municipal clients, enabling them to reuse wastewater, reduce their environmental footprint, and meet sustainability goals. Blue Foot Membranes sells its technology to original equipment manufacturers (OEMs) and system integrators who build water treatment plants.
Sector
Frontier & Industrial Tech
Verticals
Water Treatment, Waste Management, Circular Economy, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Blue Foot Membranes Comps
Public and private peers based on sector, stage, and business model.
Blue Foot Membranes Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Jul 2, 2024 | ||||
| Growth Equity | Feb 6, 2024 | ||||
| Growth Stage | Dec 1, 2023 | ||||
| VC Round | Apr 19, 2021 | ||||
| VC Round | Oct 25, 2019 | ||||
Seed | Aug 28, 2017 |
Key People
Founding team and executive leadership
Blue Foot Membranes Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Federal Holding and Investment Company | Growth Stage, Growth Equity |
| LRM | Growth Stage |
| The Innovation Fund | VC Round, Seed |
| Qbic Fund | Growth Equity, VC Round, Growth Stage |
| Clean Vision Invest | Growth Stage |
| Qbic II | VC Round, Seed |
| The Dow Chemical Company | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 12, 2025
Carlos Campos joins the board as an independent director.
- Dec 1, 2023
$16.46M round completed.
Blue Foot Membranes Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Blue Foot Membranes's valuation, stock price, and market status.
